{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T16:09:15Z","timestamp":1757779755897},"reference-count":39,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Sanofipasteur"},{"name":"Takeda Pharmaceuticals"},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["Contract # 24050"],"award-info":[{"award-number":["Contract # 24050"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH Office of Rare Diseases"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.vaccine.2014.04.017","type":"journal-article","created":{"date-parts":[[2014,4,21]],"date-time":"2014-04-21T04:00:11Z","timestamp":1398052811000},"page":"3115-3121","source":"Crossref","is-referenced-by-count":5,"title":["Consultation on dengue vaccines: Progress in understanding protection, 26\u201328 June 2013, Rockville, Maryland"],"prefix":"10.1016","volume":"32","author":[{"given":"M. Cristina","family":"Cassetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott B.","family":"Halstead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vaccine.2014.04.017_bib0005","doi-asserted-by":"crossref","first-page":"e1760","DOI":"10.1371\/journal.pntd.0001760","article-title":"Refining the global spatial limits of dengue virus transmission by evidence-based consensus","volume":"6","author":"Brady","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"7446","key":"10.1016\/j.vaccine.2014.04.017_bib0010","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"issue":"9853","key":"10.1016\/j.vaccine.2014.04.017_bib0015","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial","volume":"380","author":"Sabchareon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.04.017_bib0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4269\/ajtmh.1952.1.30","article-title":"Research on dengue during World War II","volume":"1","author":"Sabin","year":"1952","journal-title":"Am J Trop Med Hyg"},{"issue":"41","key":"10.1016\/j.vaccine.2014.04.017_bib0025","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1016\/j.vaccine.2013.06.079","article-title":"Identifying protective dengue vaccines: guide to mastering an empirical process","volume":"31","author":"Halstead","year":"2013","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2014.04.017_bib0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4269\/ajtmh.1973.22.365","article-title":"Studies on the immunization of monkeys against dengue. 1. Protection derived from single and sequential virus infections","volume":"22","author":"Halstead","year":"1973","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2014.04.017_bib0035","doi-asserted-by":"crossref","first-page":"910","DOI":"10.4269\/ajtmh.2007.77.910","article-title":"Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences","volume":"77","author":"Gibbons","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2014.04.017_bib0040","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/infdis\/jit436","article-title":"A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand","volume":"209","author":"Anderson","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.04.017_bib0045","first-page":"350","article-title":"Observations related to pathogenesis of dengue hemorrhagic fever. VI. Hypotheses and discussion","volume":"42","author":"Halstead","year":"1970","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.vaccine.2014.04.017_bib0050","first-page":"329","article-title":"Observations related to pathogenesis of dengue hemorrhagic fever. V. Examination of age specific sequential infection rates using a mathematical model","volume":"42","author":"Fischer","year":"1970","journal-title":"Yale J Biol Med"},{"issue":"12","key":"10.1016\/j.vaccine.2014.04.017_bib0055","doi-asserted-by":"crossref","first-page":"e1966","DOI":"10.1371\/journal.pntd.0001966","article-title":"Temporal dynamics of the transcriptional response to dengue virus infection in Nicaraguan children","volume":"6","author":"Popper","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2014.04.017_bib0060","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1128\/JVI.06075-11","article-title":"Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans","volume":"86","author":"Wrammert","year":"2012","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2014.04.017_bib0065","doi-asserted-by":"crossref","first-page":"e1188","DOI":"10.1371\/journal.pntd.0001188","article-title":"In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection","volume":"5","author":"de Alwis","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2014.04.017_bib0070","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/infdis\/jit119","article-title":"Human monoclonal antibodies derived from memory B cells following live attenuated dengue virus vaccination or natural infection exhibit similar characteristics","volume":"207","author":"Smith","year":"2013","journal-title":"J Infect Dis"},{"issue":"139","key":"10.1016\/j.vaccine.2014.04.017_bib0075","doi-asserted-by":"crossref","first-page":"139ra83","DOI":"10.1126\/scitranslmed.3003888","article-title":"The structural basis for serotype-specific neutralization of dengue virus by a human antibody","volume":"4","author":"Teoh","year":"2012","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.vaccine.2014.04.017_bib0080","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1073\/pnas.1317350111","article-title":"Dengue virus envelope protein domain I\/II hinge determines long-lived serotype-specific dengue immunity","volume":"111","author":"Messer","year":"2014","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.vaccine.2014.04.017_bib0085","doi-asserted-by":"crossref","first-page":"E2046","DOI":"10.1073\/pnas.1305227110","article-title":"Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells","volume":"110","author":"Weiskopf","year":"2013","journal-title":"Proc Nat Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2014.04.017_bib0090","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1128\/JVI.01826-10","article-title":"An in-depth analysis of original antigenic sin in dengue virus infection","volume":"85","author":"Midgley","year":"2011","journal-title":"J Virol"},{"issue":"23","key":"10.1016\/j.vaccine.2014.04.017_bib0095","doi-asserted-by":"crossref","first-page":"12562","DOI":"10.1128\/JVI.00871-13","article-title":"High avidity and potent neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection","volume":"87","author":"Tsai","year":"2013","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2014.04.017_bib0100","doi-asserted-by":"crossref","first-page":"e2451","DOI":"10.1371\/journal.pntd.0002451","article-title":"Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in nicaraguan dengue cases","volume":"7","author":"Lai","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2014.04.017_bib0105","doi-asserted-by":"crossref","first-page":"e2462","DOI":"10.1371\/journal.pntd.0002462","article-title":"The nicaraguan pediatric dengue cohort study: incidence of inapparent and symptomatic dengue virus infections, 2004\u20132010","volume":"7","author":"Gordon","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2014.04.017_bib0110","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/infdis\/jit273","article-title":"Reduced risk of disease during postsecondary dengue virus infections","volume":"208","author":"Olkowski","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.04.017_bib0115","first-page":"1","article-title":"Prospective cohort studies of dengue viral transmission and severity of disease","volume":"338","author":"Endy","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2014.04.017_bib0120","doi-asserted-by":"crossref","first-page":"e975","DOI":"10.1371\/journal.pntd.0000975","article-title":"Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet, Thailand","volume":"5","author":"Endy","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2014.04.017_bib0125","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1371\/journal.pmed.0050205","article-title":"Spatial and temporal clustering of dengue virus transmission in Thai villages","volume":"5","author":"Mammen","year":"2008","journal-title":"PLoS Med"},{"issue":"7","key":"10.1016\/j.vaccine.2014.04.017_bib0130","doi-asserted-by":"crossref","first-page":"e1730","DOI":"10.1371\/journal.pntd.0001730","article-title":"Fine scale spatiotemporal clustering of dengue virus transmission in children and Aedes aegypti in rural Thai villages","volume":"6","author":"Yoon","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2014.04.017_bib0135","doi-asserted-by":"crossref","first-page":"e1003723","DOI":"10.1371\/journal.ppat.1003723","article-title":"Role of humoral versus cellular responses induced by a protective dengue vaccine candidate","volume":"9","author":"Zellweger","year":"2013","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.vaccine.2014.04.017_bib0140","doi-asserted-by":"crossref","first-page":"e2274","DOI":"10.1371\/journal.pntd.0002274","article-title":"Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans","volume":"7","author":"Puschnik","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2014.04.017_bib0145","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1128\/JVI.60.3.1153-1155.1986","article-title":"Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1","volume":"60","author":"Schlesinger","year":"1986","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.04.017_bib0150","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1099\/0022-1317-68-3-853","article-title":"Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1","volume":"68","author":"Schlesinger","year":"1987","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2014.04.017_bib0155","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.antiviral.2013.03.008","article-title":"The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker","volume":"98","author":"Muller","year":"2013","journal-title":"Antiviral Res"},{"issue":"17","key":"10.1016\/j.vaccine.2014.04.017_bib0160","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1073\/pnas.1304300110","article-title":"Dengue structure differs at the temperatures of its human and mosquito hosts","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc Nat Acad Sci USA"},{"issue":"10","key":"10.1016\/j.vaccine.2014.04.017_bib0165","doi-asserted-by":"crossref","first-page":"e1002930","DOI":"10.1371\/journal.ppat.1002930","article-title":"Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope","volume":"8","author":"Austin","year":"2012","journal-title":"PLoS Pathog"},{"issue":"8","key":"10.1016\/j.vaccine.2014.04.017_bib0170","doi-asserted-by":"crossref","first-page":"e1267","DOI":"10.1371\/journal.pntd.0001267","article-title":"A single dose of the DENV-1 candidate vaccine rDEN1Delta30 is strongly immunogenic and induces resistance to a second dose in a randomized trial","volume":"5","author":"Durbin","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2014.04.017_bib0175","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/infdis\/jis936","article-title":"A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial","volume":"207","author":"Durbin","year":"2013","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2014.04.017_bib0180","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.4161\/hv.24188","article-title":"Dengue human infection model: re-establishing a tool for understanding dengue immunology and advancing vaccine development","volume":"9","author":"Thomas","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"7","key":"10.1016\/j.vaccine.2014.04.017_bib0185","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/jcu.20476","article-title":"Sonographic findings of healthy volunteers infected with dengue virus","volume":"36","author":"Statler","year":"2008","journal-title":"J Clin Ultrasound"},{"issue":"5","key":"10.1016\/j.vaccine.2014.04.017_bib0190","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/infdis\/jis744","article-title":"Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccines","volume":"207","author":"Sun","year":"2013","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2014.04.017_bib0195","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4269\/ajtmh.1989.40.444","article-title":"Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever","volume":"40","author":"Kliks","year":"1989","journal-title":"Am J Trop Med Hyg"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14005192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14005192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T03:56:25Z","timestamp":1597722985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14005192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":39,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0264410X14005192"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.04.017","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}